The hepatitis B x (HBx) gene is the smallest open reading frame of the hepatitis B virus (HBV) genome. It is conserved among all mammalian hepadnaviruses and is expressed during viral infection. While the HBx protein (pX) has been shown to trans-activate the transcription of a wide range of viral and cellular genes and to induce liver cancer in transgenic mice, the significance of pX for the life cycle of HBV itself has not been elucidated. To assess the function of pX in viral replication and virion export, we designed an X-minus mutant by introduction of a stop codon at the beginning of the HBx gene without affecting the viral polymerase gene product. Transient transfection analyses using different cell lines revealed that this X-minus mutant directs the synthesis of wild-type levels of viral proteins, replicative intermediates, and virion export. These data suggest that the expression of the highly conserved HBx gene is not central for the life cycle of HBV in vitro but may be involved in the pathogenicity of hepadnavirus infection, including liver cancer development.
Human hepatitis B virus (HBV) belongs to a group of hepatotropic DNA viruses (hepadnaviruses) that includes the hepatitis viruses of the woodchuck, ground squirrel, tree squirrel, Pekin duck, and heron. The hepadnavirus genomes have similar sizes and structures and replicate via reverse transcription of an RNA intermediate, a replication strategy characteristic for RNA-containing retroviruses (25) . Three of the four open reading frames code for proteins with essential functions for the viral life cycle, i.e., DNA polymerase-reverse transcriptase, hepatitis B surface antigen (HBsAg), and hepatitis B core/e antigen (HBc/eAg). The fourth open reading frame, termed the hepatitis B x (HBx) gene, codes for a 17-kDa protein which is expressed during the natural course of HBV infection (8, 26 ) and which appears to be a novel protein kinase (27) . The HBx protein (pX) has been shown to trans-activate the transcription of a wide range of viral and cellular genes (2, 5, 9, 22-24, 29, 30) and to induce liver cancer in transgenic mice (11) . While most previous studies analyzed the trans-activating potential of pX by cotransfection of pX expression vectors with different target constructs, the endogenous function of pX in the life cycle of HBV itself has not been elucidated.
To assess the contribution of pX to viral gene expression, replication, and virion export in vitro, we designed an X-minus mutant by site-directed mutagenesis of a wild-type HBV genome via introduction of a stop codon at the beginning of the HBx gene in a replication-competent HBV construct. Site-directed mutagenesis was carried out by polymerase chain reaction (PCR) amplification of the replication-competent, incomplete HBV DNA dimer adw R9 (3) with a primer spanning the genome region consisting of nucleotides (nt) 821 to 842 (EcoRI site start position 1) and a primer spanning the region consisting of nt 1415 to 1388 and carrying a C-to-T mutation at nt 1397. This mutation results in a stop codon mutation in the HBx gene (codon 8) without affecting the polymerase gene product (Fig. 1) . The PCR product was gel purified and cloned into pCR 1000 (Invitrogen, San Diego, Calif.). The EcoRV-BamHI fragment was isolated to replace the corresponding fragment in the replication-competent, incomplete HBV DNA dimer adw R9 (nt 1044 to 1403), yielding the mutant clone HBX-21. From this clone a complete head-to-tail dimer (HTD), designated HBX-21 HTD, was constructed in the EcoRI site of pGEM7Zf(+) (Promega, Madison, Wis.). The functional competence of wild-type and mutant clones was assessed by transfection of human hepatoma cell lines and primary rat hepatocytes followed by detection and characterization of viral proteins, RNA, and replicating DNA species in cell lysates and culture media (3).
The synthesis and export of the viral proteins HBsAg and HBc/eAg into the culture medium was first assessed with the human hepatoma cell line HuH-7 (16) . The cells were grown to near confluence in Eagle minimal essential medium supplemented with 10% fetal bovine serum. Cells were transfected as described by Chen and Okayama (4); 20 ,ug of DNA was routinely used per 100-mm-diameter plate. An aliquot of culture medium was removed daily and analyzed for HBsAg by a radioimmunoassay (Centocor, Malvern, Pa.) and for HBc/eAg by an enzyme immunoassay (Abbott, North Chicago, Ill.). As shown in Fig. 2 virions, culture media from adw R9-and HBX-21-transfected cells were subjected to cesium chloride equilibrium centrifugation, and then viral antigens and replicating DNA species were analyzed. HuH-7 cells were grown and transfected as described above. Culture medium (10 ml) was harvested 5 days after transfection. Solid cesium chloride (1.5 g) was added to 4.5 ml of medium, and the mixture was centrifuged at 235,000 x g for 60 h at 4°C (21) . The gradients were fractionated into 350-pdl samples. The density of the fractions was determined by weight. HBsAg and HBc/eAg were measured as described above after a 1:10 dilution of the fractions with phosphate-buffered saline. For DNA extraction, two gradient fractions each (700 [lI) were pooled, diluted to 5 ml with 10 mM Tris-HCl (pH 7.4)-i mM EDTA and centrifuged for 5 h as described above. DNA was isolated from the pellet and analyzed as described previously (3) . As shown in Fig. 4 (Table 1 ). These findings suggest that the stop codon mutation in codon 8 of the HBx gene leads to a loss of the trans-activating potential of these clones without affecting viral gene expression, replication, or export of virions. In addition, the absence of trans-activating activity of DHBV HTD indicates that the HBx gene-related sequences identified in the core gene of DHBV (6) have no transactivating potential in the cell culture system used.
Transfection efficiency was assessed by the detection of hepatitis B core antigen (HBcAg) in cells transfected with wild-type or X-minus mutant HBV DNA. HuH-7 cells were grown and transfected as described above. Five days after (19) , more studies are needed to assess the molecular effect of pX on the regulation of viral genes. In view of the wild-type levels of viral replication and virion export directed by the X-minus mutant, the different antigen levels observed in HepG2 cells do not affect the viral life cycle, however.
Furthermore, in primary adult rat hepatocytes, the wildtype and X-minus mutant constructs resulted in synthesis of identical amounts of viral transcripts of 2.1 and 3.6 kb (data not shown) as well as secretion of identical amounts of HBsAg and HBc/eAg into the culture medium (Fig. 2, right  panel) . The In conclusion, on the basis of our data, the expression of the full-length HBx protein is not required for viral transcription, replication, or synthesis of structural proteins and therefore appears not to be central to the life cycle of HBV in vitro. The biological significance of carboxy-terminal pX peptides potentially translated from transcripts initiated at downstream AUGs is unclear at present. Recent findings with simian immunodeficiency virus (SIVmac 239) demonstrate that the nef gene, which is highly conserved among lentiviruses and nonessential for viral replication in vitro, is required in vivo for maintaining a high virus load and for full pathogenic potential (10) . To assess the potential contribution of pX to hepadnavirus propagation and pathogenicity in vivo, we have therefore initiated long-term studies with the woodchuck model (20) , using WHV-positive culture media from HuH-7 cells transfected with a replication-competent HTD of wild-type WHV and an X-minus mutant of the WHV genome (2a) . Most importantly, these in vivo studies should determine the contribution of pX to the development of liver cancer, extending the recent findings with transgenic animals (11, 13 ) in a natural model of hepadnavirus hepatocarcinogenesis (18 
